One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Diabetes, Obesity and Metabolism
doi : 10.1111/dom.15134
Diabetes, Obesity and Metabolism: Volume 26, Issue 9
Role of protein arginine methyltransferase 1 in obesity-related metabolic disorders: Research progress and implications
doi : 10.1111/dom.15640
Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity
doi : 10.1111/dom.15693
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial
doi : 10.1111/dom.15685
Exploring causal effects of gut microbiota and metabolites on body fat percentage using two-sample Mendelian randomization
doi : 10.1111/dom.15692
Biological aging mediates the associations of metabolic score for insulin resistance with all-cause and cardiovascular disease mortality among US adults: A nationwide cohort study
doi : 10.1111/dom.15694
Genetic variants of LEAP2 are associated with anthropometric traits and circulating insulin-like growth factor-1 concentration: A UK Biobank study
doi : 10.1111/dom.15695
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study
doi : 10.1111/dom.15697
Decreased complexity of glucose time series index associated with adverse pregnancy outcomes in gestational diabetes mellitus
doi : 10.1111/dom.15698
Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus
doi : 10.1111/dom.15699
The selective serotonin reuptake inhibitors, sertraline and paroxetine, improve islet beta-cell mass and function in vitro
doi : 10.1111/dom.15701
Type 2 diabetes, glycaemic traits, structural brain capacity and cognitive function: A Mendelian randomization analysis
doi : 10.1111/dom.15702
Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective
doi : 10.1111/dom.15703
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial
doi : 10.1111/dom.15705
A predictive model for medium-term weight loss response in people with type 2 diabetes engaging in behavioural weight management interventions
doi : 10.1111/dom.15706
Association of KLF14 rs4731702 gene polymorphism with metabolic phenotype in young patients with type 1 diabetes
doi : 10.1111/dom.15707
Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all-cause mortality in adults, compared with bisphosphonates: An analysis of real-world, cohort data, with a systematic review and meta-analysis
doi : 10.1111/dom.15708
Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction-associated fatty liver disease: An exploratory study
doi : 10.1111/dom.15709
Real-life hypoglycaemia partially blunts the inflammatory response to experimental hypoglycaemia in people with type 1 diabetes
doi : 10.1111/dom.15712
Physical activity in relation to metabolic health and obesity: The Feel4Diabetes study
doi : 10.1111/dom.15713
Association between new-onset atrial fibrillation and dementia among individuals with type 2 diabetes
doi : 10.1111/dom.15714
Association between low cognitive performance and diabetes-related health indicators across racial and ethnic groups in adults with diabetes
doi : 10.1111/dom.15715
Differences in imeglimin response in subgroups of patients with type 2 diabetes stratified by data-driven cluster analysis: A post-hoc analysis of imeglimin clinical trial data
doi : 10.1111/dom.15716
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study
doi : 10.1111/dom.15717
Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta-analysis
doi : 10.1111/dom.15718
Incretin-based therapy and the risk of diabetic foot ulcers and related events
doi : 10.1111/dom.15721
Metabolic dysfunction-associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes
doi : 10.1111/dom.15723
The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli-D randomized controlled trial
doi : 10.1111/dom.15724
Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta-analysis of randomized clinical trials
doi : 10.1111/dom.15725
Once-weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant-level meta-analysis of the ONWARDS 1–5 trials
doi : 10.1111/dom.15726
The effects of intermittent fasting on body composition and cardiometabolic health in adults with prediabetes or type 2 diabetes: A systematic review and meta-analysis
doi : 10.1111/dom.15730
Changes in thyroid hormones predict weight regain in patients with obesity who undergo metabolic surgery
doi : 10.1111/dom.15731
Effects of light-intensity physical activity on cardiometabolic parameters in young adults with overweight and obesity: The SED-ACT randomized controlled crossover trial
doi : 10.1111/dom.15732
Association of overweight/obesity and overweight/obesity-related metabolic dysfunction-associated steatotic liver disease in young adults with coronary artery calcification later in life
doi : 10.1111/dom.15733
Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long-term kidney outcomes in people with diabetes receiving sodium-glucose cotransporter-2 inhibitors
doi : 10.1111/dom.15734
Neuregulin4-ErbB4 signalling pathway is driven by electroacupuncture stimulation to remodel brown adipose tissue innervation
doi : 10.1111/dom.15735
Randomised comparison of intravenous and subcutaneous routes of glucagon-like peptide-1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes
doi : 10.1111/dom.15736
Adverse event comparison between glucagon-like peptide-1 receptor agonists and other antiobesity medications following bariatric surgery
doi : 10.1111/dom.15737
Metformin monotherapy versus predominantly older non-metformin antidiabetic medications for cerebrovascular risk in early type 2 diabetes management
doi : 10.1111/dom.15739
Impairments of insulin and glucagon sensitivity in Chinese women with gestational diabetes mellitus
doi : 10.1111/dom.15740
The association of diabetes with progression of sleep-disordered breathing based on a prospective cohort
doi : 10.1111/dom.15742
Inhibition of inflammation and apoptosis through the cyclic GMP-AMP synthase-stimulator of interferon genes pathway by stress granules after ALKBH5 demethylase activation during diabetic myocardial ischaemia-reperfusion injury
doi : 10.1111/dom.15743
Renal function as an effect modifier of intensive glucose control in delaying cognitive function decline among individuals with type 2 diabetes: A revisit to the ACCORD MIND trial
doi : 10.1111/dom.15744
Development and validation of 10-year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning-based methods
doi : 10.1111/dom.15745
The interaction effect between BMI, diabetes and age at diabetes onset on the risk of thyroid cancer: A population-based cohort study in Shanghai, China
doi : 10.1111/dom.15746
The global burden of disease attributable to high body mass index in 204 countries and territories: Findings from 1990 to 2019 and predictions to 2035
doi : 10.1111/dom.15748
Efficacy of Aspirin for primary prevention among adults with high-risk type 2 diabetes in the ACCORD trial
doi : 10.1111/dom.15753
Reversal of insulin resistance in people with obesity by lifestyle-induced weight loss does not impact the proportion of circulating 12α-hydroxylated bile acids
doi : 10.1111/dom.15754
Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction-associated steatotic liver disease but is not altered by 6 weeks of exercise training
doi : 10.1111/dom.15755
Vulvovaginal candidiasis and type 2 diabetes: A nationwide retrospective cohort study
doi : 10.1111/dom.15757
Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes
doi : 10.1111/dom.15760
Association of type III collagen turnover with cardiovascular outcomes and impact with canagliflozin in the CANVAS Program: A post hoc analysis
doi : 10.1111/dom.15761
Associations of body mass index, waist circumference and the weight-adjusted waist index with daily living ability impairment in older Chinese people: A cross-sectional study of the Chinese Longitudinal Healthy Longevity Survey
doi : 10.1111/dom.15762
Evaluation of time in tight range and the glycaemia risk index in adults with type 1 diabetes using an advanced hybrid closed loop system: A 1-year real-world assessment
doi : 10.1111/dom.15766
Visceral fat mass dynamics in a 2-year randomized STrength versus ENdurance training trial in people with obesity
doi : 10.1111/dom.15767
Paediatric type 1 diabetes mellitus: A comparison between multi-injection therapy and advanced hybrid closed-loop pump in the first year after diabetes onset
doi : 10.1111/dom.15704
No association between semaglutide and postoperative pneumonia in people with diabetes undergoing elective surgery
doi : 10.1111/dom.15711
Accuracy of the professional flash glucose monitoring system FreeStyle Libre Pro in hospitalized individuals with type 2 diabetes mellitus receiving standardized basal-bolus insulin therapy
doi : 10.1111/dom.15719
Regional socioeconomic deprivation associated with the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes in Germany
doi : 10.1111/dom.15741
Implications of antenatal 1-hour postload plasma glucose (≥ 11.6 mmol/L) for postpartum diabetes and cardiometabolic risk assessment in women with gestational diabetes: Post hoc analysis from the CHIP-F study
doi : 10.1111/dom.15722
Effects of intensive treatment of Chinese women with gestational diabetes on the risk of offspring being overweight from 3 to 8 years of age
doi : 10.1111/dom.15770
Correction to “Cardiovascular health metrics defined by Life's Essential 8 scores and subsequent macrovascular and microvascular complications in individuals with type 2 diabetes: A prospective cohort study�
doi : 10.1111/dom.15806
